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Thomas H. Marwick, MD, PHD, MPH, Alison J. Venn, PHDH ypertension contributes substantially tothe burden of disease in developed nationsand, increasingly, in the developing world
(1). Although recognition of high blood pressure (BP)
seems simple, 20% to 30% of individuals have undi-
agnosed hypertension (2), and 50% to 70% of diag-
nosed hypertensive subjects fail to attain target BP
(2). A history of diagnosed hypertension is present
in 10% of young adults, with rates of observed hy-
pertension between 4% and 19% (3), a problem that
is likely to increase with the burgeoning obesity
epidemic. Clinic BP measurements carry risks of
both overestimation (“white coat hypertension”) and
underestimation (“masked hypertension”) of hy-
pertension severity. Repeated measurement is one
means of overcoming this regression dilution bias
arising from the inaccuracy of single measurements
(4). An imaging marker of the effect of hypertensive
damage to the cardiovascular system, analogous to
use of glycosylated hemoglobin in diabetes, might
be beneﬁcial.SEE PAGE 2679In this issue of the Journal, Kishi et al. (5) have used
the CARDIA (Coronary Artery Risk Development in
Young Adults) study to demonstrate a positive rela-
tionship between BP exposure over 25 years and left
ventricular (LV) dysfunction. In this epidemiologic
study, the average age at entry was 25 years; at follow-
up, it was 50 years. Several noteworthy features make
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stage; in particular, the Central Illustration of the pa-
per (5) demonstrates the relationship between
myocardial function and BP among individuals who
were normotensive by standard criteria. Second,
although not the paper’s primary goal, the effect of BP
exposure on LV function appeared to lack a speciﬁc
threshold. These ﬁndings are concordant with previ-
ous population studies showing a relationship
between BP and cardiac function, measured using
cardiac magnetic resonance in the MESA (Multi-Ethnic
Study of Atherosclerosis) study (6) and echocardiog-
raphy to assess myocardial strain in the Framingham
study (7). These epidemiologic data suggest BP expo-
sure is associated with myocardial impairment.
Although various myocardial imaging techniques
can detect subclinical myocardial dysfunction, echo-
cardiography’s feasibility andwide availabilitymake it
attractive. Assessment of diastolic function, although
predictive of heart failure (HF) and outcome in patients
at risk of HF, remains complex, involving measure-
ment of transmitral ﬂow, tissue Doppler, and left atrial
volume (8), leading to practical challenges with
reproducibility (9). Strain is a fundamental property of
matter that expresses its deformation in response to an
applied force. The initial echocardiographic method-
ology for strain measurements was on the basis of tis-
sue Doppler, with commensurate challenges related to
Doppler alignment (10). Approximately 10 years ago,
the technique of speckle tracking overcame this limi-
tation by directly measuring displacement of specular
reﬂectors within the myocardium (10). The most
widely used strain signal is longitudinal deformation,
which reﬂects subendocardial function, the region
most susceptible to injury. Most investigators have
used spatial averaging to overcome errors introduced
by noise, reporting this as global longitudinal strain,
reﬂecting the overall deformation of the myocardium.
Typically, strain is expressed as a negative number,
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Over time, increasing systolic blood pressure (SBP) and the evolution of myocardial
strain or diastolic dysfunction (DD) may lead to the development of clinical heart
failure (HF).
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2689normal strain being approximately 20% (11). Strain
rate equals the rate of change of strain, and the provi-
sion of the temporal component in assessing this pro-
vides a parameter closer to invasive indices of
contractility (12). Unfortunately, speckle tracking’s
temporal resolution is much less than that obtainable
using tissue Doppler; consequently, most in-
vestigators have found strain rate to be less robust and
less predictive than strain.
Conventionally, strain is expressed as a systolic
parameter, but both active and passive components of
LV ﬁlling produce a strain signal that can be measured
in diastole (12). Strain is afterload-dependent, so the
effect of hypertension on strain reﬂects not only the
consequences of prolonged elevation on myocardial
structure but also the BP at the time of measurement.
The existing published data on strain suggests it is
substantially more sensitive to subtle changes of LV
function than ejection fraction, and thus it has been
adopted into guidelines to assess cardiotoxicity from
chemotherapy (13). The prognostic value of strain,
particularly in patients with normal or near-normal
ejection fraction (14), is important in characterizing
strain as an intermediate step on the way to clinical
HF. Thus, the use of diastolic functional markers and
strain add echocardiographic information previously
provided by measuring LV hypertrophy (15).
The observation that cumulative exposure to BP
from young adulthood is associated with LV function
in middle age raises critical questions about the
importance of BP even earlier in life and the need for
longitudinal studies commencing in childhood (16).
Cumulative exposure to high body mass index and
BP from childhood was associated with LV hypertro-
phy in adulthood in the Bogalusa Heart Study (17).
Previous work has documented the impact of child
and adult BP on subclinical atherosclerosis, measured
as intima-medial thickness (18) and coronary calcium
score (19). Indeed, adding intermediate outcomes to
risk analysis can increase the predictive capacity of
clinical scoring (20).
CONCLUSIONS
The use of an intermediate endpoint (Figure 1) would
resolve some of the uncertainties in hypertensionmanagement, including the susceptibility of some
“at-risk” subjects to end-organ damage at a BP less
than the current treatment threshold, together with
the ambiguity of clinic measurements. Because risk
is a conditional probability applied to groups rather
than individuals, identifying subclinical target organ
damage also may facilitate a more personalized
approach to therapy. Echocardiography’s wide avail-
ability and relatively low cost make this an attractive
candidate for such a marker. To date, conventional
markers of structural (LV hypertrophy) or functional
change (ejection fraction) have been ineffective
for this purpose because of a lack of precision, reli-
ability, or both. Prospective studies will be needed to
document that identiﬁcation of subclinical LV
dysfunction facilitates decision making and improves
outcome in hypertension.
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